It's "shareholder-linked" (probably not "driven"), but yes, upvoted. Nonetheless, even when with grave faults in the path, Google has managed to give us marvellous, paramount free resources (Google Street, Google Museum...), and would have given more (Google Books - if the negotiation had succeeded). I am grateful.
not my field so I can't judge how useful it is but assuming this data can be used for drug discovery and their ToS limiting to non-commercial use only. Does DeepMind plan on selling this data to pharmaceutical companies?
the Google DeepMind PR team can't catch a break, shame it makes no sense to me - if someone's in the field maybe they could explain to the rest of us if this is a big deal, just a PR move, or nah?
I think orliesaurus meant the PR team is unable to rest because the rest of Deepmind is so prolific and keep coming out with new things for them to announce
I'm comfortable programming but others who also do mol bio may be less so or may not recognize when Claude is going off the rails.
https://deepmind.google/blog/alphagenome-atlas-a-predictive-...
They are only announcing a cache. The origin for the cache is not discussed.
In particular, the question of whether to trust the predictions is not addressed. For that, I think the citation is from January:
https://www.nature.com/articles/s41586-025-10014-0
1. https://www.youtube.com/watch?v=U0aToL5C-bQ
2. https://www.youtube.com/watch?v=b2qw3rDNX0Q